Board of Directors
Top leaders from academia, government, and industry, representing a variety of biotech disciplines, serve on Bio Nebraska’s Board of Directors.
Current Directors
Josh Johnson, Chairman
Director of Biologics Operations, Huvepharma
Michael Dixon, Ph.D.
President and CEO, UNeMed Corporation
Rachel Hurley
Midwest Government Affairs Manager, Bayer Crop Science
Matthew Kreifels
Vice President of Sales, Streck Inc.
Tyler Martin, M.D.
CEO, Adjuvance Technologies
Kyle Nixon
Director of Supply Chain for the Americas, Novozymes
Todd Sneller
Sneller Associates
Charles Bicak, Ph.D.
Senior Vice Chancellor, University of Nebraska at Kearney
Ronnie Green, Ph.D.
Chancellor, University of Nebraska-Lincoln
Christopher Kratochvil, M.D.
Associate Vice Chancellor, University of Nebraska Medical Center
Gary Madsen, Ph.D.
CEO, ProTransit Nanotherapy
Lyle Middendorf
Sr. VP and Chief Technical Officer, LI-COR Biosciences
Laurie Reagan
Plant Manager, BD
*Beginning in 2021
Amy Thompson
Director of Business Development, McCarthy Building Companies
*Beginning in 2021
Executive Leadership
Rob Owen
Executive Director
Sasha Forsen
Assistant Director